Healthcare >> CEO Interviews >> June 2, 2003

Michael Bonney – Cubist Pharmaceuticals Inc (cbst)

MICHAEL W. BONNEY has served as Cubist's President and Chief Executive Officer of Cubist Pharmaceuticals, Inc., and as a member of the company's Board of Directors since June 2003. From January 2002 until June 2003, he served as President and Chief Operating Officer of Cubist. From 1995 to 2001, he held various positions of increasing responsibility at Biogen, Inc., including Vice President, Sales and Marketing from 1999-2001. While at Biogen, Mr. Bonney built the commercial infrastructure for the launch of Avonex. Prior to that, Mr. Bonney held various positions in sales, marketing and strategic planning at Zeneca Pharmaceuticals, ending his 11-year career there serving as National Business Director. Mr. Bonney received a BA in Economics from Bates College. Profile
TWST: Could we begin with a brief historical sketch of the

company and an overview of things as they are now?

Mr. Bonney: Cubist was founded in 1993 with a focus on a specific

scientific